Annual CAPEX
$2.64 M
-$12.64 M-82.70%
December 31, 2023
Summary
- As of February 7, 2025, ASND annual capital expenditures is $2.64 million, with the most recent change of -$12.64 million (-82.70%) on December 31, 2023.
- During the last 3 years, ASND annual CAPEX has fallen by -$21.97 million (-89.26%).
- ASND annual CAPEX is now -90.78% below its all-time high of $28.67 million, reached on December 31, 2021.
Performance
ASND CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
N/A
September 30, 2024
Summary
- ASND quarterly capital expenditures is not available.
Performance
ASND Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CAPEX
N/A
September 30, 2024
Summary
- ASND TTM capital expenditures is not available.
Performance
ASND TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
ASND CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -82.7% | - | - |
| 3 y3 years | -89.3% | - | - |
| 5 y5 years | -15.4% | - | - |
ASND CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -90.8% | at low | ||||
| 5 y | 5-year | -90.8% | at low | ||||
| alltime | all time | -90.8% | +606.7% |
Ascendis Pharma A/S CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | $216.20 K(-358.3%) | $1.69 M(-35.9%) |
| Dec 2023 | $2.64 M(-82.7%) | -$83.70 K(-107.9%) | $2.64 M(-63.4%) |
| Sep 2023 | - | $1.06 M(+111.2%) | $7.22 M(-19.0%) |
| Jun 2023 | - | $501.90 K(-56.9%) | $8.91 M(-26.7%) |
| Mar 2023 | - | $1.17 M(-74.1%) | $12.16 M(-20.4%) |
| Dec 2022 | $15.28 M(-46.7%) | $4.49 M(+63.4%) | $15.28 M(-7.6%) |
| Sep 2022 | - | $2.75 M(-26.7%) | $16.54 M(-38.5%) |
| Jun 2022 | - | $3.75 M(-12.4%) | $26.90 M(-2.1%) |
| Mar 2022 | - | $4.28 M(-25.6%) | $27.47 M(-4.2%) |
| Dec 2021 | $28.67 M(+16.5%) | $5.76 M(-56.1%) | $28.67 M(+0.8%) |
| Sep 2021 | - | $13.11 M(+203.7%) | $28.43 M(+27.7%) |
| Jun 2021 | - | $4.32 M(-21.3%) | $22.27 M(-4.5%) |
| Mar 2021 | - | $5.49 M(-0.5%) | $23.32 M(-5.2%) |
| Dec 2020 | $24.61 M(+326.2%) | $5.52 M(-20.5%) | $24.61 M(+20.7%) |
| Sep 2020 | - | $6.94 M(+29.1%) | $20.39 M(+37.7%) |
| Jun 2020 | - | $5.38 M(-20.7%) | $14.81 M(+51.9%) |
| Mar 2020 | - | $6.78 M(+423.5%) | $9.75 M(+68.8%) |
| Dec 2019 | $5.78 M(+84.7%) | $1.29 M(-4.7%) | $5.78 M(+0.2%) |
| Sep 2019 | - | $1.36 M(+326.5%) | $5.76 M(+0.6%) |
| Jun 2019 | - | $318.40 K(-88.6%) | $5.73 M(-1.3%) |
| Mar 2019 | - | $2.80 M(+118.9%) | $5.81 M(+85.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $3.13 M(+193.4%) | $1.28 M(-3.2%) | $3.13 M(+50.3%) |
| Sep 2018 | - | $1.32 M(+233.8%) | $2.08 M(+120.5%) |
| Jun 2018 | - | $396.50 K(+216.4%) | $943.80 K(+19.6%) |
| Mar 2018 | - | $125.30 K(-46.8%) | $789.30 K(-25.9%) |
| Dec 2017 | $1.07 M(+43.3%) | $235.70 K(+26.5%) | $1.07 M(+13.7%) |
| Sep 2017 | - | $186.30 K(-23.0%) | $937.50 K(+1.4%) |
| Jun 2017 | - | $242.00 K(-39.7%) | $924.20 K(-6.9%) |
| Mar 2017 | - | $401.60 K(+273.2%) | $993.20 K(+33.5%) |
| Dec 2016 | $743.70 K(-35.5%) | $107.60 K(-37.8%) | $743.80 K(-28.3%) |
| Sep 2016 | - | $173.00 K(-44.4%) | $1.04 M(+7.9%) |
| Jun 2016 | - | $311.00 K(+104.3%) | $962.00 K(-20.4%) |
| Mar 2016 | - | $152.20 K(-62.1%) | $1.21 M(+4.8%) |
| Dec 2015 | $1.15 M(+114.1%) | $401.70 K(+313.7%) | $1.15 M(+43.3%) |
| Sep 2015 | - | $97.10 K(-82.6%) | $804.80 K(+3.7%) |
| Jun 2015 | - | $557.20 K(+474.4%) | $775.80 K(+67.1%) |
| Mar 2015 | - | $97.00 K(+81.3%) | $464.30 K(-13.8%) |
| Dec 2014 | $538.60 K(-66.1%) | $53.50 K(-21.4%) | $538.60 K(+11.0%) |
| Sep 2014 | - | $68.10 K(-72.3%) | $485.10 K(+16.3%) |
| Jun 2014 | - | $245.70 K(+43.4%) | $417.00 K(+143.4%) |
| Mar 2014 | - | $171.30 K | $171.30 K |
| Dec 2013 | $1.59 M(+324.2%) | - | - |
| Dec 2012 | $374.10 K | - | - |
FAQ
- What is Ascendis Pharma A/S annual capital expenditures?
- What is the all time high annual CAPEX for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S annual CAPEX year-on-year change?
- What is the all time high quarterly CAPEX for Ascendis Pharma A/S?
- What is the all time high TTM CAPEX for Ascendis Pharma A/S?
What is Ascendis Pharma A/S annual capital expenditures?
The current annual CAPEX of ASND is $2.64 M
What is the all time high annual CAPEX for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high annual capital expenditures is $28.67 M
What is Ascendis Pharma A/S annual CAPEX year-on-year change?
Over the past year, ASND annual capital expenditures has changed by -$12.64 M (-82.70%)
What is the all time high quarterly CAPEX for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high quarterly capital expenditures is $13.11 M
What is the all time high TTM CAPEX for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high TTM capital expenditures is $28.67 M